January 2010 contents - Archive by Issue - BioProcess International

Feedback Advertise Reprints About Help Contact

Advanced Search

Upstream Processing Downstream Processing Manufacturing Analytical Facilities

Archive by Issue Archive by Article Type Supplements

CMC Forum

January 2010

January 2010, Vol.8 No.1

On the Cover

Production vessels lined up in Roche’s biotech manufacturing plant, building #95, in Basel, Switzerland (winner of the 2009 ISPE facility-of-the-year award, announced in November). www.roche.com

Focus On…

COMPLIANCE

Hurry Up and Wait?

Michalle Adkins

BioProcess International, Vol. 8, No. 1, January 2010, pp. 10–16

BioProcess Technical

Improved HCP Quantitation By Minimizing Antibody Cross-Reactivity to Target Proteins

Xing Wang, Thomas Schomogy, Kristine Wells, Ned M. Mozier

BioProcess International, Vol. 8, No. 1, January 2010, pp. 18–24

Nutrient Supplementation Strategies for Biopharmaceutical Production, Part 3

Richard Fike

BioProcess International, Vol. 8, No. 1, January 2010, pp. 24–31

Primary Clarification of Very High-Density Cell Culture Harvests By Enhanced Cell Settling

Emily B. Schirmer, Michael Kuczewski, Kathryn Golden, Blanca Lain, Carissa Bragg, John Chon, Marco Cacciuttolo, Gregory Zarbis-Papastoitsis

BioProcess International, Vol. 8, No. 1, January 2010, pp. 32–39

Vendor Voice

PAT-Based In-Line Buffer Dilution

Thomas Malone, Michael Li

BioProcess International, Vol. 8, No. 1, January 2010, pp. 40–49

Global Marketplace

BioProcess International, Vol. 8, No. 1, January 2010, pp. 50–51

Global Meetingplace

Biopharmaceutical Development and Production Week

BioProcess International, Vol. 8, No. 1, January 2010, p. 52

Elucidation

Quantitative Crowdsourcing

Leslie Fine

BioProcess International, Vol. 8, No. 1, January 2010, p. 56

The Best of GE Healthcare: Tools for vaccine processes

In vaccine development and manufacturing, GE Healthcare provides a suite of scalable solutions from cell culture through purification to analysis, which offer flexibility and economy, improve purity and secure quality.

Microcarriers and disposable bioreactors for MDCK and Vero cell culture
Secure cell propagation with adherent cells at reduced cost and with increased flexibility

DNA removal from influenza virus culture
HTPD and DoE for development and optimization of a chromatography step for the removal of host cell derived genomic DNA

Editors' Blog

On the (BPI) Road (Part 2)

More Travel Tips from the Editor in Chief

Practical Considerations for DoE Implementation in Quality By Design

BioProcess International Conference & Exhibition

Contractor Responsibilities in Outsourced Pharmaceutical Quality Control Testing

Measuring Manufacturing Cost and Its Impact on Organizations

Fluorescence-Activated Cell Sorting for CGMP Processing of Therapeutic Cells

I'm Losing Cell Viability and Function at Different Points in My Process, and I Don't Know Why!

Current Issue